Prolocor and Slingshot Biosciences Announce Publication of ‘Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets’ in Bioanalysis
The Prolocor pFCG® test measures the expression of a specific protein on the platelet surface which this study demonstrates is a reliable prognostic tool to...
Aronora Secures Investment From New York Blood Center
Aronora, Inc., a clinical-stage biotech poised to revolutionize blood clot treatment and prevention, today announced it has closed an investment from NYBC Ventures, a venture...